234 related articles for article (PubMed ID: 15102686)
21. [beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].
Brabletz T; Jung A; Dag S; Reu S; Kirchner T
Verh Dtsch Ges Pathol; 2000; 84():175-81. PubMed ID: 11217438
[TBL] [Abstract][Full Text] [Related]
22. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
[TBL] [Abstract][Full Text] [Related]
23. Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome.
Grabsch H; Takeno S; Noguchi T; Hommel G; Gabbert HE; Mueller W
Histopathology; 2001 Aug; 39(2):141-9. PubMed ID: 11493330
[TBL] [Abstract][Full Text] [Related]
24. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
[TBL] [Abstract][Full Text] [Related]
25. Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and MT1-MMP in colorectal carcinomas.
Hlubek F; Spaderna S; Jung A; Kirchner T; Brabletz T
Int J Cancer; 2004 Jan; 108(2):321-6. PubMed ID: 14639622
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.
Ougolkov AV; Yamashita K; Mai M; Minamoto T
Gastroenterology; 2002 Jan; 122(1):60-71. PubMed ID: 11781281
[TBL] [Abstract][Full Text] [Related]
28. P53 and beta-catenin in colorectal cancer progression.
Valentini AM; Pirrelli M; Renna L; Armentano R; Caruso ML
Curr Pharm Des; 2003; 9(24):1932-6. PubMed ID: 12871177
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.
Lugli A; Zlobec I; Baker K; Minoo P; Tornillo L; Terracciano L; Jass JR
J Clin Pathol; 2007 May; 60(5):534-9. PubMed ID: 16816167
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study.
Resnick MB; Routhier J; Konkin T; Sabo E; Pricolo VE
Clin Cancer Res; 2004 May; 10(9):3069-75. PubMed ID: 15131045
[TBL] [Abstract][Full Text] [Related]
31. MUC1 expression in colorectal carcinoma: Clinicopathological correlation and prognostic significance.
Díaz Del Arco C; Garré P; Molina Roldán E; Lorca V; Cerón Nieto MÁ; Fernández Aceñero MJ
Rev Esp Patol; 2018; 51(4):204-209. PubMed ID: 30269770
[TBL] [Abstract][Full Text] [Related]
32. Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: correlation with early tumor invasion.
Miyazawa K; Iwaya K; Kuroda M; Harada M; Serizawa H; Koyanagi Y; Sato Y; Mizokami Y; Matsuoka T; Mukai K
Virchows Arch; 2000 Nov; 437(5):508-13. PubMed ID: 11147171
[TBL] [Abstract][Full Text] [Related]
33. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma.
Fujito T; Sasaki Y; Iwao K; Miyoshi Y; Yamada T; Ohigashi H; Ishikawa O; Imaoka S
Hepatogastroenterology; 2004; 51(58):921-4. PubMed ID: 15239213
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma.
Matsuda K; Masaki T; Watanabe T; Kitayama J; Nagawa H; Muto T; Ajioka Y
Jpn J Clin Oncol; 2000 Feb; 30(2):89-94. PubMed ID: 10768872
[TBL] [Abstract][Full Text] [Related]
36. Intracellular distribution of beta-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps.
Herter P; Kuhnen C; Müller KM; Wittinghofer A; Müller O
J Cancer Res Clin Oncol; 1999; 125(5):297-304. PubMed ID: 10359135
[TBL] [Abstract][Full Text] [Related]
37. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
38. Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin.
Wen Y; Caffrey TC; Wheelock MJ; Johnson KR; Hollingsworth MA
J Biol Chem; 2003 Sep; 278(39):38029-39. PubMed ID: 12832415
[TBL] [Abstract][Full Text] [Related]
39. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas.
Wang JY; Chang CT; Hsieh JS; Lee LW; Huang TJ; Chai CY; Lin SR
J Surg Oncol; 2003 Aug; 83(4):253-60. PubMed ID: 12884239
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of nuclear β-catenin at invasive front in rectal carcinoma is associated with lymph node metastasis and poor prognosis.
Wang L; Zhang X; Li Z; Chai J; Zhang G; Yu Z; Cheng Y; Hu S
Clin Transl Oncol; 2014 May; 16(5):488-94. PubMed ID: 24043496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
